PREVENTIONGENETICS INC.

In News

What to know about Exact Sciences. The Madison company was sold to Abbottfor $23 billion. - Milwaukee Journal Sentinel

Milwaukee Journal Sentinel - Nov 20, 2025

Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Cancer Testing for More Patients - PR Newswire

PR Newswire - Jan 09, 2022

PreventionGenetics Assumes the Management of Sponsored Genetic Testing Program for Three Rare Genetic Diseases: Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1 & Hereditary ATTR Amyloidosis - BioSpace

BioSpace - Mar 13, 2025

Here's How Much a $1000 Investment in Exact Sciences Made 10 Years Ago Would Be Worth Today - Yahoo Finance

Yahoo Finance - Oct 07, 2025

EXAS Stock Price, News & Analysis - Stock Titan

Stock Titan - Apr 24, 2025

Exact Sciences Q4 Earnings Match Estimates, Revenues Beat, Stock Up - TradingView

TradingView - Feb 19, 2026

Free genetic testing for AHP offered by Alnylam Act in US, Canada - Porphyria News

Porphyria News - Mar 19, 2025

Rare Disease Genetic Testing Market Size | CAGR Of 13.1% - Market.us

Market.us - Apr 18, 2023

UK Rare Disease Genetic Testing Market Size & Outlook, 2033 - Grand View Research

Grand View Research - Sep 02, 2024

PreventionGenetics Receives FDA Approval for its Companion Diagnostic Genetic Test as a Class II Medical Device - PR Newswire

PR Newswire - Jun 30, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment